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Sommaire
Problématique: Il existe divers effets biologiques associés à l’exposition au chrome, ces
effets dépendent de la spéciation de ce métal. Seulement l’état d’oxydation trivalent
[Cr(III)] et hexavalent [Cr(VI)] présentent un intérêt pour la santé humaine. Le rein est
considéré comme étant un des organes cibles de la toxicité due aux composés du chrome.
La toxicité rénale, hépatique et dermique a été rapportée chez les ouvriers d’industries
exposés au Cr(VI). Cependant, l’information concernant les mécanismes néphrotoxiques
des composés du chrome est présentement très limitée.
Objectifs: Étudier in vitro le potentiel néphrotoxique (le potentiel d’induire les lésions
cellulaires) du bichromate de potassium [Cr(VI)] et du chlorure de chrome [Cr(III)] en
utilisant les tranches de cortex rénal isolé chez le rat. En outre, étudier la possibilité que
la formation de métabolites cellulaires réducteurs, la formation d’espèces réactives
oxygénées (H202, 02, 0H) ou encore la perte de l’imperméabilité des pores
mitochondriaux (PPM) soient impliquées dans l’induction de ces lésions cellulaires.
D’où l’étude comparative des mécanismes d’action néphrotoxique du Cr(VI) et du Cr(III)
dans les tranches de cortex rénal isolé chez le rat.
Méthodologie: La viabilité cellulaire et la surproduction de la peroxydation des lipides
dans les tranches de cortex rénal isolé chez le rat après exposition au bichromate de
iv
potassium [Cr(VI)] et au chlorure de chrome [Cr(III)] ont été respectivement mesurées
par le test de MTT (la mesure de la toxicité par détermination du sel de tétrazolium en
formazan) et par la formation de MDA (malondialdéhyde). En outre, le rôle
physiologique d’antioxydants tels la glutathion, la glutathion réductase (GSSG-R), la
mélatonine, les vitamines C (acide ascorbique), E (a-tocophérol) et celui de la PIPM dans
l’induction de ces lésions cellulaires corticales rénales par le bichromate de potassium et
le chlorure de chrome a été étudié.
Résultats: Article 1. Le Cr(VI) engendre la cytotoxicité et la surproduction du stress
oxydatif (tel que mesuré par la formation de MDA et la déplétion de la réserve des thiols:
groupements sulffiydryles non liés aux protéines) à reformuler dans les tranches de cortex
rénal isolé chez le rat. L’induction du stress oxydatif survient après celle de la
cytotoxicité. Le prétraitement des tranches de cortex rénal avec le mannitol et le diméthyl
thiourée (DMTU) avant le traitement avec le Cr(VI) a réduit de façon significative
l’induction de la surproduction de la peroxydation des lipides par le Cr(VI). Cependant,
ce prétraitement n’a pas réduit l’induction de la cytotoxicité. Ceci suggère que le radical
hydroxyle est impliqué dans l’induction de la peroxydation des lipides par le Cr(VI) et
non dans l’induction de la toxicité de ce dernier. Par contre la catalase et la superoxyde
dismutase (SOD) n’ont pas réduit de façon significative l’induction de cette toxicité,
suggérant que le peroxyde d’hydrogène et le radical anion superoxyde ne sont pas
impliqués dans la toxicité du Cr(VI). Le traitement simultané des tranches de cortex rénal
Vavec le glutathion et le Cr(VI) ou leur prétraitement avec l’acide ascorbique avant d’être
traitées avec le Cr(VI) ont réduit significativement les lésions cellulaires et la
peroxydation des lipides. Bien que le Cr(VI) induise la PIPM, celle ci ne semble pas joué
un rôle significatif dans l’induction de la cytotoxicité. La glutathion réductase non plus
n’a pas joué un rôle significatif dans cette cytotoxicité. Article 2. Le Cr(III) induit la
cytotoxicité à reformuler dans les tranches de cortex rénal isolé chez le rat, mais n’induit
pas la surproduction du stress oxydatif. Le traitement simultané des tranches de cortex
rénal avec le glutathion et le Cr(III) augmente de façon significative l’induction de la
cytotoxicité et la surproduction de la peroxydation des lipides. Par contre leur
prétraitement avec l’acide ascorbique suivi du traitement avec le Cr(III) diminue
significativement la cytotoxicité, alors que la vitamine E n’a pas réduit de façon
significative cette cytotoxicité. À reformuler, l’induction de la cytotoxicité induite par le
bichromate de potassium est environ 8-fois plus forte que celle induite par le chlorure de
chrome dans ce modèle expérimental.
Conclusion: Les composés du chrome [Cr(VI) et Cr(III)] induisent la cytotoxicité dans
les tranches de cortex rénal isolé chez le rat. Ces résultats suggèrent que le bichromate de
potassium est potentiellement plus toxique que le chlorure de chrome dans les tranches de
cortex rénal isolé chez le rat. Le bichromate de potassium induit la surproduction du
stress oxydatif comparativement au chlorure de chrome qui n’induit pas le stress oxydatif
L’antioxydant vitamine C peut jouer un rôle préventif dans la toxicité de ces deux
vi
composés de chrome. D’autre part, le glutathion joue un rôle différentiel dans l’induction
de la toxicité de ces composés.
Mot clés: chrome, néphrotoxicité, cytotoxicité, le mécanisme, la peroxidation des lipides,
les formes d’oxygène réactives, la perte de l’imperméabilité des pores mitochondriaux
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Summary
Background: The biological effects associated with chromium exposure are diverse and
depend upon chromium speciation. Only the trivalent [Cr(III)] and hexavalent [Cr(VI)]
forms of chromium are important for human health. The kidney is considered to be one of
the target organs for toxicity of chromium compounds. Renal, hepatic and dermal toxicity
have been reported in industrial workers exposed to Cr(VI). However, the information
regarding the mechanisms of chromium compounds-induced nephrotoxicity is at present
very limited.
Objectives: To study the nephrotoxicity potential (potential to induce cellular injury) of
both potassium dichromate {Cr(VI)] and chromium chloride [Cr(III)] using isolated rat
renal cortical suces in vitro. Furtherrnore, to investigate whether renal cellular injury due
to these chromium compounds are mediated by the formation of cellular reductive
metabolism andlor reactive oxygen species (ROS) (such as hydrogen peroxide,
superoxide anion and/or hydroxyl free radicals) andlor mitochondrial permeability
transition (MPT). Hence, to compare the mechanism ofnephrotoxic action ofCr(VI) and
Cr(III) compounds in isolated renal cortical slices.
Methods: Potassium dichromate [Cr(VI)] - and chromium chloride [Cr(III)] -induced
reduction of ceil viability (as measured by MTT test: measurement of the toxicity with
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diphenyl-tetrazolium bromide) and increase in lipid peroxidation (LPO) [as measured by
malondialdehyde (MDA) formation] were examined in isolated rat renal cortical suces.
furthermore, the effects ofphysiological cellular antioxidants (such as glutathione (GSH),
vitamin C (ascorbic acid), vitamin E (u-tocopherol), glutathione reductase (GSSG-R),
and melatonin) andlor MPT on both potassium dichromate- andlor chromium
chloride-induced renal cortical cellular damage were examined.
Resuits: Article 1. Cr(VI) induced both concentration- and time-dependent cytotoxicity
(ceil viability) and oxidative stress [MDA formation and nonprotein-sulffiydryl group
(NP-SH) depletion]. But Cr(VI)-induced oxidative stress occurs later than
Cr(VI)-induced cytotoxicity in isolated renal cortical slices. Pre-treatment with mannitol
and dimethyl thiourea (DMTU) only reduced Cr(VI)-induced LPO but not
Cr(VI)-induced cytotoxicity, suggesting that hydroxyl ftee radicals were involved in
Cr(VI)-induced LPO, but not cytotoxicity. Catalase and superoxide dismutase (SOD)
failed to reduce such toxic effects, suggesting hydrogen peroxide and superoxide anion
were not involved in Cr(VI)-induced toxic effects. Co-treatment with excess glutathione
or pre-treatment with excess ascorbic acid reduced Cr(VI)-induced cellular damage and
LPO. Although Cr(VI) induced mitochondrial permeability transition (MPT), such MPT
played a non significant role in Cr(VI)-induced cytotoxicity. Glutathione reductase
(GSSG-R) did not show any important role in Cr(VI)-induced nephrotoxicity. Article 2.
Cr(III) induced both concentration- and time-dependent cytotoxicity in isolated rat renal
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cortical suces, but no effects on oxidative stress. Co-treatment with excess GSH increased
Cr(III)-induced cytotoxicity and LPO. Pre-treatment with excess vitamin C, but flot
vitamin E, prevented Cr(III)-induced cytotoxicity. Comparing these chromium
compounds, potassium dichromate-induced cytotoxicity is found to be about 8-fold
higher than that of chromium chloride in this experimental system.
Conclusion: Both chromium(VI) and chromium(III) compounds induced cytotoxicity in
isolated renal cortical suces of rat. Cr(VI) possesses greater toxicity than Cr(III). Cr(VI)
also induced the oxidative stress by increasing MDA formation and decreasing NP-SH
content, but these occurred following the cytotoxicity occurred. Cr(III) has flot shown
such effects. Hydroxyl free radicals are involved in Cr(VI)-induced LPO but flot
cytotoxicity. GSH plays a differential role in chromium compounds-induced toxicity. for
Cr(VI), it plays a protective role by decreasing Cr(VI)-induced cell viability loss and
MDA formation; for Cr(III), it enhances Cr(III)-induced cytotoxicity and lipid
peroxidation. Vitamin C is a powerful antioxidant to prevent both Cr(VI) and
Cr(III)-induced toxicity.
Key words: chromium compounds, nephrotoxicity, cytotoxicity, mechanisrn, lipid
peroxidation, reactive oxygen species, mitochondrial permeability transition
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SECTION 1:
GENERAL INTRODUCTION
21.1 Introduction
1.1.1 Chromium
Chromium is naturally occurring in rocks, animais, plants, sou, and in volcanic dust and
gases. It is present in the environment in several different forms. The most important
forms are trivalent (III) and hexavalent (VI) chromium. Trivalent chromium occurs
naturally in the environment and is an essential trace metal required by the human body
to promote the action of insulin in body tissues so that the body can use sugar, protein,
and fat (Mertz, 1993). It is the most stable chromium compound and poorly soluble in
water at pH ranging from 4-11 except for the acetate, chloride (hexahydrate), and nitrate
saits. Hexavalent chromium is primarily produced by anthropogenic source. It is the
second most stable chromium compound and is a strong oxidizing agent, especially in
acid media. Its compounds usually exist as oxides or as oxohalides. They are soluble in
water. Hexavalent chromium compounds traverse celi membranes well and are reduced to
trivalent compounds intracellularÏy (Barceloux, 1999). The relationship between the
hexavalent and trivalent states of chromium is described by the equation:
Cr2O72 + 14 H+ 6 electrons — 2Cr3 + 7 H2Q + 1.33 eV
Cr(VI) Cr(III)
The difference in electric potential between Cr(VI) and Cr(III) reflects the strong
oxidizing potential ofhexavalent chromium and the substantial energy (1.33 eV) required
to oxidize the trivalent chromium to the hexavalent form. For practical purposes, it can be
3stated that this oxidation neyer occurs in biological systems. But the reduction of
hexavalent chromium occurs spontaneously in the organism, unless present in an
insoluble form (WHO, 1988).
1.1.2 Occupational and environmental exposure
People can be exposed to chromium by breathing air, drinking water, or eating food
containing chromium or through skin contact with chromium compounds. The reference
dose (RfD) of US Environmental Protection Agency (EPA) for trivalent chromium is
lmg/kg/d based on a chronic animal study, in which the NOAEL is based on
administering 5% chromium trioxide (Cr203) in the diet of rats. For hexavalent chromium,
the RfD is 5 Lg/kg/d based on a one-year drinking water study in Sprague-Dawley rats.
EPA also sets the maximum level of Cr(III) and Cr(VI) allowed in drinking water at
100[g/L (ATSDR, 2000).
About 80 ¾ of the chromium mined goes into metallurgical applications (such as
ferrochromium intermediates for stainless steels, cast irons, and nonferrous alloys), 15 %
is used in chromium chemicals manufacture (including chrome plating, the manufacture
of dyes and pigments, leather tanriing, wood preserving, textiles, and toner for copying
machines) and the remainder is used in refractory application (like drilling rnud, rust and
corrosion inhibitors) (Barceloux, 1999). Occupational Safety and Health Administration
(OSHA) regulates chromium levels in the workplace air. The occupational exposure
4limits for an 8-hour workday, 40-hour workweek are 500 g CrIm3 for water-soluble
chromic {Cr(III)] or chromous [Cr(II)] saits and 1,000 gJm3 for metallic chromium
{Cr(0)] and insoluble saits. The level of chromium trioxide (chrornic acid) and other
chromium(VI) compounds in the workplace air should flot be higher than 52 ig/m3 for
any period of time (ATSDR, 2000).
1.1.3 Metabolism
Cr(VI) compounds are easier absorbed than Cr(III) compounds. Under physiological
conditions, Cr(VI) exists as a chromate oxy-anion and crosses the ceil membrane through
non-specific phosphate/sulfate anionic transporters. Cr(VI) undergoes rapid metabolic
reduction, producing the intermediate Cr(V) and Cr(IV) species and, ultimately, to Cr(III).
When intracellular reductant levels are present in gross excess over Cr(VI), the initial
step involves a two electron reduction to Cr(W) followed by one electron reduction to
Cr(III) (O’Brien et al, 2003). In blood, Cr(III) binds to proteins, such as transferrin, in
plasma and distributes widely throughout the body. Cr(VI) entering the blood stream is
taken up selectively by erythrocytes, reduced and bound to haemoglobin. It has found
high-Ievel concentration of chromium in the kidneys, lungs, and spleen (Dayan and Paine,
2001).
1.1.4 Excretion
The main routes for the excretion of chromium are via kidney/urine and biÏe/faeces
5(Shrivastava et ai, 2002). The kidney rapidly excretes most of the absorbed chromium
with littie retention of chromium in tissues. The urinary haif-life of Cr(VI) ranges from
15 to 41 hr. Erythrocytes release chromium slowly and the possibility of limited release
of chromium from a slow compartment is from several montlis to a few years. Urinary
chromium concentrations are the highest when exposure is predominantly to Cr(VI)
compounds (Barceloux, 1999). Almost ail ofintravenously injected chromium is excreted
via the urine and only 2% is found in the faeces (WHO, 1988). Urinary excretion of total
chromium lias been used for decades as a biomonitoring tool to evaluate exposure to
chromium compounds in occupational settings (Kerger et ai, 1996). Biliary excretion
accounts for about 10% of the elimination of chromium with smaller amounts of
chromium appearing in hair, milk, naiis and sweat (Barceloux, 1999).
1.2 Chromium-induced toxic effects
The toxic effects associated with chromium are diverse and depend upon metal speciation.
Cr(VI) is generally much more toxic than Cr(III). Chromium has been extensively
demonstrated to induce acute and chronic toxicity, neurotoxicity, dermatotoxicity,
genotoxicity, carcinogenicity, immunotoxicity, and generai environmentai toxicity
(Bagchi et ai, 2002).
1.2.1 General effects
In adult hurnan subjects, the lethai orai dose of soluble chromate [Cr(VI)] is considered to
6be 50-70 mg!kg b.w. soluble chromates. The clinical features of acute poisoning are
vomiting, diarrhoea, haemorrhage and blood loss into the gastrointestinal tract, causing
cardiovascular shock. If the patient survives for more than about 8 days, the major effects
resulting from oral ingestion of toxic doses of Cr(VI) are liver and kidney necrosis. The
acute ingestion of large amounts of Cr(VI) compounds produces acute tubular necrosis
(ATN), marked interstitial changes, and renat failure. Chronic low-dose exposure to
chromium can induce low molecular weight (LMW) proteinuria and then produce chronic
renal injury in chromium workers. Hepatic necrosis occurs afier the acute ingestion of
very large quantities of Cr(VI) compounds (Dayan and Paine, 2001; Barceloux, 1999;
Wedeen and Qian, 1991).
Chromium(VI) compounds are pulmonary sensitizers, producing a generalized irritation
of the conjunctiva and mucous membranes, nasal perforations, and a contact dermatitis.
Inhalation of Cr(VI) compounds causes rnarked irritation of the respiratory tract. Thus,
ulceration and perforation of the nasal septum have occurred frequently in workers
employed in the chromate producing and Cr(VI)-using industries. Rhinitis, bronchospasm,
pneumonia and bronchial asthrna have been reported in workers exposed to Cr(VI)
compounds (Dayan and Paine, 2001). Cr(VI) was associated with hurnan lung cancer in a
case report describing a chrome pigment worker with an adenocarcinoma in his nasal
turbinate bone in 1 890. Since the initial report, Cr(VI) compounds have been declared as
a potent occupational carcinogen. IARC and the US toxicology program recognize Cr(VI)
7as a known human carcinogen (Wise $r. et ai, 2002).
Both Cr(VI) and Cr(III) compounds may cause dermatitis in sensitized individuais.
Chromic acid is a corrosive that produces inflammation and ulceration of the skin.
Chronic uicers of the skin and acute irritative dermatitis have been consistentiy reported
in workers exposed to chromium containing materiais. Direct skin contact with chromium
compounds eiicits an allergic response, characterized by eczema or dermatitis, in
sensitized individuals. Contact dermatitis has been a serious problem in industries where
solutions of Cr(VI) salts handled, as well as in workers exposed to stainless steei welding
fumes. Chromium sensitivity is a ciassic deiayed-type (class W) hypersensitivity reaction.
The formation of the ultimate hapten is considered to involve Cr(III) (Dayan and Paine,
2001).
1.2.2 Toxicity in experimental research
In contrast to Cr(III) compounds, Cr(VI) compounds are oxidizing agents capable of
directiy inducing tissue damage and cause a dose-dependent ioss in ceii viabiiity. Cr(VI)
is reduced to Cr(III) in ceils. This reduction is assumed to be a prerequisite for chromate
toxicity because only the trivalent form is able to interact with critical target moiecules
inside a ccli (Dartsch et ai, 1998; Appenroth and Kersten, 1990).
Dartsch et al (1998) investigated the nephrotoxicity and hepatotoxicity of Cr(III) and
$Cr(VI) compounds in kidney epitheliai celi and liver epitheliai ceil, respectively. The
resuits showed that Cr(VI), but flot Cr(III), had an acute cytotoxic effect and caused a
dose-dependent loss in ceil viability. The effective dose that caused 50% of ccli death was
5 jimol/L of Cr(VI) for kidney epithelial ceils and 50 imo1/L for liver epithelial ceils,
indicating that kidney epithelial celis are 10 times more sensitive towards Cr(VI)
treatment than liver epitheliai ceils. In primary cultured hepatocytes, Gunaratnam and
Grant (2004; 2002) found that exposure ofcells to 1, 5, 10 and 50 tM Cr(VI) compounds
resulted in the loss of the celi cytoskeleton, and accompanied with membrane blebbing
and shrinking of the celi. Staining of the ceils with annexin V and propidium iodide
showed that Cr(VI) induced apoptosis at Ïow concentrations and necrosis at higher
concentrations. A significant decrease of celi viability induced by Cr(VI) also were
observed in isolated hepatocytes of goldfish (Krumsclmabel and Nawaz, 2004).
The cytotoxicity of both particulate (water-insolubie, PbCrO4) and soluble (Na2CrO4)
Cr(VI) in primary human bronchial flbroblasts (PHBFs) were deterrnined. Both
compounds induced concentration-dependent cytotoxicity affer a 24 hr exposure in
PHSFs. The relative survivai was 87, 46, 26 and 2% after exposure to 0.1, 0.5, 1 and 5
1g/cm2 PbCrO4, respectively, and 74, 57, 13 and 0% after exposure to 1, 2.5, 5 and 10
!IM Na2CrO4, respectiveiy, indicating that Cr(VI) compounds are cytotoxic to human
lung ceils (Wise Sr. et ai, 2002). The sirnilar resuits were found in normal human iung
epitheliai celis at concentration ranges from 0.2 to 200 jiM K2Cr2O7. The toxic effect was
9associated with increased levels of intracellular phosphoprotein and subsequent release of
inflammatory cytokines IL-6 and IL-8 (Pascal and Tessier, 2004). Ning and Grant (1999)
investigated the cytotoxicity of Cr(VI) in immortalized rat osteoblast celis in vitro using
aikaline phosphatase (ALP) activity as an index of toxicity. Cr(VI) caused a
concentration-dependent decrease in ALP activity.
Biedermann and Landolph (1990) compared the role of valence state chromium
compounds on induction of cytotoxicity in diploid human fibroblasts (HFC) from
foreskins and found Cr(VI) compounds (PbCrO4, Na2CrO4 and Cr03) were 1000-fold
more cytotoxic to HFC (average 50% lethal dose 0.5 M) than Cr(III) compounds (CrC13,
Cr203, and Cr2S3) (average 50% lethal dose 500 The similar resuits were obsewed
by Flores and Perez (1999) in several human and murine ceil unes. Venier et al (1982)
also found that potassium dichromate {Cr(VI)] was higher cytotoxic than chromium
chloride or other chromium(III) compounds in cultured hamster celis.
Cr(VI) compounds induced DNA damage, gene mutation, sister chromatid exchange
(SCE), chromosomal aberrations, celi transformation and dominant lethal mutations in a
number of targets, including animal in vivo, animal and human ceils in vitro. The
negative resuits were obtained for Cr(III) compounds in the large majority of tests for
DNA damage and gene mutation in bacteria (Dayan and Paine, 2001). But Blasiak and
Kowalik (2000) found that potassium dichromate induced DNA damage in the
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lymphocytes, and CrCI3 caused greater DNA migration than K2Cr2O7.
Ovarian dysftinction in aduit Swiss albino female mice was observed foilowing Cr(VI)
exposure through drinking water. Ovaries of the highest dose (750 ppm for 20 days)
showed large numbers of atretic follicles and congestion in stromal tissue compared to
the rest of the treated groups. The number of ova recovered from superovulated
Cr(VI)-treated animais showed significant decrease in the 500 and 750 ppm dosed groups.
The duration of estms cycle increased in highest dosed (750 ppm) group (Murthy et ai,
1996).
1.3 Mechanisms of chromium-induced toxic effects
A large number of studies demonstrated that chromium-induced toxicity involved in
oxidative stress, DNA damage, apoptotic ccii death and aitered gene expression. As a
generai rule, Cr(VI) is much more toxic than Cr(III). Cr(VI) was transported through
mammalian ccli membranes by the carboxylate, sulphate and phosphate carrier systems.
The intracellular reduction of Cr(VI) implies the generation of short-iived species of
pentavalent [Cr(V)] and tetravaient [Cr(W)] chrornium with affinities for cellular
constituents that may differ from that of Cr(III). Those chromium intermediates, radicals,
and reactive oxygen species (ROS) can subsequently attack macromolecules and iead to
DNA damage (Bagchi et ai, 2002; Dayan and Paine, 2001; Tsou et ai, 1999).
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1.3.1 Apoptosis
Cr(VI)-induced apoptosis was first reported in Chinese hamster ovary (CR0) celis.
Treated with sodium chromate or lead chromate particles, the CHO celis decreased in
survival in colony-forming efficiency assays. And the ceil growth, DNA synthesis and
protein synthesis were also inhibited, respectively. Morphological features of apoptosis
inciuding nuclear fragmentation were observed in more than 90% of detached
non-adherent ceils and up to 22% of adherent celis. But the untreated celis remained
morphoiogically normai (Blankenship et ai, 1994; 1997).
The apoptosis caused by a set of Cr(III)-complexes in human lymphocytes was first
reported by Rajaram research group in 1995. Only two of five Cr(III) complexes are
found to cause apoptosis. Manygoats et al (2002) studied the ceiiular effects of Cr(III)
and found the morphologicai damage caused by chromium picolinate, picolinic acid and
chromic chloride in CHO AA8 celis by using transmission electron microscopy (TEM)
study. The resuits showed 83% of analyzed celis having swoilen mitochondria with
degraded cristate. Apoptosis was identified by nuclear convolution and fragmentation,
and cytoplasmic biebbing.
1.3.2 Oxidative stress
Chromium compounds-induced oxidative stress mainly includes enhanced production of
ROS, increased lipid peroxidation and genomic DNA fragmentation. It is caused by an
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imbalance between free radical generation and antioxidant defence systems. It also resuits
in decreased antioxidant defence levels, altered redox enzyiie activity, and DNA damage
(Shi et ai, 2004).
1.3.2.1 Reactive Oxygen Species (ROS) and Iipid peroxidation (LPO)
Reactive oxygen species (ROS) refer to hydrogen peroxide (H202), superoxide anion (02)
and hydroxyl radicaÏ (‘OH). Both Cr(VI) and Cr(III) are biologically active oxidation
states and involved in redox cyciing with the production of ROS. A large number of
studies have shown that chromium compounds exhibit the abiiity to produce reactive
oxygen species, resulting in lipid peroxidation, DNA damage, and depietion of
sulffiydryis (Rai-ris and Shi, 2003; Travacio et ai, 2001; Stohs and Bagchi, 1995).
In both mice and rats, acute or chronic oral administration of chromium(VI) compounds
could increase production of ROS and lipid peroxidation in liver or brain, enhance
excretion of urinary lipid metaboiites, DNA fragmentation and apoptotic celi death. In
potassium dichromate [Cr(VI)]-treated rats, the excretion of ail four Iipid metabolites
were 1.7- to 3.0-foid greater than for chromium chioride [Cr(III)]-treated animais. Ii
mouse brain homogenates, the oxidative stress aiso occurred afler oraily treated
potassium dichrornate 25 mg/kg per day. The resuits indicated that Cr(VI)-induced
oxidative stress resulting in tissue damaging effects might contribute to the toxicity and
carcinogenicity of chromium (Bagchi et ai, 2002; 1997a; 1995a; 1995b and Travacio et ai,
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2001). In isolated rat hepatocytes, addition of K2Cr2O7 resulted in rapid glutathione
oxidation, RO$ formation, iipid peroxidation (Pourahmad et ai, 2003). In A549 ceils,
ROS levels increased in proportion to the concentration of Cr(VI). The increases were
diminished by pretreatment with catalase, superoxide dismutase, or D-mannitol (Kim et
ai, 2003). Bagchi et al (2000) aïso observed approximately 3.1 to 6-fold increases in
hydroxyl radical production following incubation of the K562 ceils with K2Cr2O7 at 12.5
and 25 ILM concentrations. In the rat heart homogenate, hydroxyl radical formation and
the iipid peroxidation leveis were increased with an increase on the concentrations of
Cr(VI) solution added (Coudray et ai, 1992).
Cr(III) was thought to be reiatively nontoxic. However, Ozawa and Hanaki (1990)
demonstrated that Cr(III) can be reduced to Cr(II) by the biological reductants L-Cysteine
and NADH, and in tum, the newly formed Cr(II) reacts with hydrogen peroxide to
produce hydroxyl radical, which can be detected by electron spin resonance and HPLC.
The resulting hydroxyl radicais are presumably responsible for tissue damaging effects.
Cr(III) is capable of producing free radicais from both hydrogen peroxide and iipid
hydroperoxides. Incubation of chrornium chloride with hydrogen peroxide at
physiological pH generated hydroxyl radical. And diethylenetriamine pentacetic acid
significantiy reduced hydroxyl radical yield. Incubation Cr(III) with hydroperoxide
compounds resulted in the generation of lipid hydroperoxide-derived free radicals (Shi et
ai, 1993). Assessment ofthe enhanced production ofreactive oxygen species for exposure
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to Cr(III) compounds in cultured macrophage J774A. 1 celis found that the lipid
peroxidation, superoxide anion, hydroxyl radical production and DNA fragmentation are
determined to increase up to 1.0 to 1.8 folds (Bagchi et ai, 1997b). Balamurugan et al
(2002) observed that Cr(III)-induced apoptosis involved the generation of ROS in human
peripheral blood lymphocytes by examination of morphology, flow cytometry and DNA
fragmentation. Pre-treatment of lymphocytes with antioxidants completely abrogate
apoptosis.
1.3.2 Formation of ïntermediate: reactîve Cr(V) and Cr(IV)
Chromium intermediates, including Cr(W) and Cr(V), possibly generated during the
metabolic reduction of Cr(VI) to Cr(III). Since Cr(V) is a putative DNA-damaging
species that may be involved in the carcinogenic activity of Cr(VI) compounds. Cr(VI)
does not react with isolated DNA, the reduction of Cr(VI) to lower oxidation states afier
entering the human system bas been considered an important step in Cr(VI)-induced
DNA damage and carcinogenesis. Liu and Shi’s (2001) studies in vitro and in model
systems indicated that Cr(V) and its related free radical formation are involved in the
mechanism of Cr(VI)-induced toxicity and carcinogenesis. Electron spin resonance
measurements on solutions and isolated powders provide direct evidence for the
formation of long-iived Cr(V) intermediates in the reduction of Cr(VI) by glutathione
reductase in the presence of NADPH and for the hydroxyi radical formation during the
glutathione reductase catalyzed reduction of Cr(VI). Cr(V) intermediates catalyze
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generation of hydroxyl radicais ftom hydrogen peroxide through a Fenton-like reaction
(Shi and DaTai, 1989; 1990). Dillon et al (199$) observed that two Cr(V) complexes were
genotoxic and exhibited similar potencies to that of Cr(VI) in vitro micronucieus assay in
V79 Chinese hamster lung celis. On the histology of mice liver, Cr(VI) and Cr(V)
produced reversible hepatic damage in a time-dependent maimer. Cr(V) toxic effects had
proved to be more rapid than with Cr(VI) (Pires das Neyes et ai, 2002). In Hojo et al’s
research (1999), iipid peroxidation induction by Cr(IV) and Cr(V) compounds is more
effective in both liver and kidney homogenates than that by the Cr(VI) compounds. These
resuits suggest the possible participation of Cr(W) and Cr(V) in Cr(VI)-enhanced
toxicity.
1.3.3 Role of physiologica] antioxidants
Two steps affect Cr(VI) reduced to Cr(III): (1) the diffusion of the Cr(VI) into ceils by
non-specific anion carrier and (2) the intracellular reduction of Cr(VI) to Cr(III) keeping
the cytoplasmic concentration of Cr(VI) low (Arsian et ai, 1987). On physiological
condition, there are a great diversity of intracellular reductants or antioxidants being
proposed to contribute to the reduction of Cr(VI), including both non-enzymatic and
enzymatic pathways. Non-enzymatic pathway involves compounds such as reduced
glutathione, cysteine, hydrogen peroxide, and the vitamins (ascorbic acid, a-tocopherol
and riboflavin). Enzymatic reduction lias also been demonstrated by glutathione reductase,
DT-diaphorase, NADPH cytochrome c reductase and cytochrome P450 dependent
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systems. The contribution of these non-enzymatic and enzymatic pathways wiil vary in
different celis and tissues of the body and also under different pathophysiological
condition (Shi et ai, 2004; Gunaratnam and Grant, 2001).
1.3.3.1 Glutathione (GSH) and cysteine
In living celis, the most abundant low molecular thiol is glutathione, which is known to
be present at millimolar concentrations inside ceils and to act as a protective
physiological antioxidant in biological systems (Sugiyama, 1992). Glutathione can reduce
Cr(VI) at significant rate at physiological pH in vitro, and its occurrence in millimolar
concentrations in ceils makes it a primary candidate for Cr(VI) reduction in vivo
(Standeven and Wetterhahn, 1991). GSH is capable of reacting with Cr(VI) to produce
Cr(V), Cr(W), GSH thiol radicals and Cr(III)-GSH complexes. Cysteine is another
potentially important intracellular reductant of Cr(VI). Similar to GSH, cysteine forms
coordinate amino acid-Cr(III) temary adducts with DNA, which represent potentially
mutagenic lesions (O’Brien et ai, 2003). Incubation of human red blood ceils with an
excess of Na2CrO4 (10 mM) decreased the GSH content of the celis to 10% of the
original amount (Wiegand et ai, 1984).
The role of GSH in chromate-induced toxicity was a controversial question. Appenroth
and Kersten (1990) found that an increase of renal glutathione concentration by
pretreatment of rats with acetylcysteine caused an increase of proteinuria caused by
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Na2Cr2O7. furthermore, the renal glutathione concentration of young rats was iower than
those of aduits, and chromate-induced nephrotoxicity was expressed less in young than
that in aduit rats. Glutathione depleted hepatocytes were resistant to Cr(VI) toxicity and
much less dichiorofluorescin oxidation occuned (Pourahrnad and O’Brien, 2001). The
reduction of Cr(VI) by cysteine resulted in the formation of mutagenic Cr(III)-DNA
adducts in the absence of oxidative DNA damage (Quievryn et ai, 2001).
In contrast, most studies suggested that GSH may piay a protective role in
Cr(VI)-induced toxicity. In mice, Cr(VI)-induced nephrotoxicity was accompanied by
decreased renal GSH and glutathione reductase (GSSG-R) levels. Pretreatment with
buthionine sulfoximine (BSO), an inhibitor of GSH biosynthesis, enhanced
Cr(VI)-induced nephrotoxicity and remarkabiy diminished kidney GSH and GSSG-R
levels. Pretreatment with glutathione methyl ester, a GSH-supplying agent, prevented
Cr(VI) ftom exerting a harmfui effect on mouse kidney and restored kidney GSH level
(Hojo and Satorni, 1991). Injection (i.p.) with a thiol compound to mice immediately after
injection of chromate, mortality, omithine carbamyl transferase activity in the senim and
chromium content in the iiver were diminished remarkably compared with mice injected
with chromate alone. Meanwhiie the urinary chromium excretion was increased. The
resuits indicated that some thiol compounds are useful for treating chrornate-induced
toxicity when they are given immediately after intake of chromium (Susa et ai, 1994).
Standeven and Wetterhahn (1991) found the effect of GSH depletion on Cr(VI)-induced
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nephrotoxicity in male Sprague-Dawley rats. Cr(VI) caused a dose-dependent decrease in
ceil viability and intracellular reduced glutathione levels in hepatocytes and osteobiasts
(Gunaratnam and Grant, 2001; Ning and Grant, 2000).
1.3.3.2 Vitamins
Vitamin C is present normally in millimolar concentrations in humans and animais. It
may have antiviral, anticancer, and antimutagenic activity. Vitamin E is located in
biological membranes and plays an important antioxidant role against oxidative damage
of the membrane. In rats, it was observed that vitamin C and vitamin E significantiy
inhibited chromate-induced nephrotoxicity by measured as the concentration of
chromium in renal cortex and medulla, urinary volume, protein excretion as weli as biood
urea nitrogen concentration (Appenroth and Winnefeld, 1998). In animal research, it bas
been shown that dietary pretreatment cf rats or guinea pigs with vitamin E or vitamin C
protected bone marrow celis from chromium(VI)-induced cytotoxicity (Chorvatovicova
et ai, 1991). In experimental studies, endogenous vitamin C in rat lung, liver, kidney and
hurnan plasma effectively reduces Cr(VI) to Cr(III). The administration cf exogenous
ascorbic acid bas been advocated in the treatment cf systemic chromium poisoning and
chromium dermatitis to enhance the extracellular reduction cf Cr(VI) to the less
bioavailable Cr(III). Parenteral ascorbic acid 0.5-5 g/kg te rats significantly reduced
chromium-induced nephrotoxicity when adrninistered 30 min before parenteral sodium
dichromate and up to 1 hr after parenteral sodium chromate dosing (Bradberry and Vale,
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1999). The protective role of vitamin E on Cr(VI)-induced cytotoxicity and iipid
peroxidation was observed in primary cultures of rat hepatocytes or in Chinese hamster
V-79 celis (Susa et ai, 1996; Sugiyama et ai,1989a;1989b). Pretreatment with vitamin E
resulted in a decrease of DNA singie-strand breaks produced by Na2CrO4 (Sugiyama,
1991). However, under certain conditions, vitamin C acts as a prooxidant, producing
H702 and ftee radicals. Pretreatment of human erythrocytes with vitamin C (1 mM) and
vitamin E (20 iM) significantly increased chromate-induced human erythrocytes
haemoglobin oxidation in a time-dependent manner (Femandes et ai, 2000).
In animal study, it is found vitamin B2 could decrease the nephrotoxic effect of chromate
in young and aduit rats (Appenroth et ai, 1996). Pretreatment with vitamin B resulted in a
decrease of cytotoxicity after exposure to the iethal concentration of chromate (15 iM)
but did not affect the cytotoxicity at sublethal concentration of Cr(VI) in Chinese hamster
V-79 celis. However, in V79 celis, treatment with vitamin B2 enhanced an increase of
chromate-induced DNA iesions (Sugiyama, 1991).
1.3.3.3 Antioxidant enzymes
Some antioxidant enzymes invoived in the reduction of chromium compounds, including
giutathione reductase, DT-diaphorase, NADPH cytochrome e reductase and cytochrome
P450 dependent systems. Giutathione reductase appears to play an important roie in the
enzymatic meduction of Cr(VI). Using carmustine (BCNU), an inhibitor of glutathione
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reductase, markedly protected the ceils from cytotoxicity in isolated rat hepatocytes and
in immortalized rat osteoblasts (FFC ceils). Both DT-diaphorase and cytochrome P450
play only a minor role in detoxifying Cr(VI) and!or its metabolites (Gunaratnam and
Grant, 2001; Ning and Grant, 2000). In Pourahmad and O’Brien’s study (2001),
DT-diaphorase and glutathione reductase did flot show any significant effect on
Cr(VI)-induced cytotoxic aiterations. However, phenylimidazole, an inhibitor ofCYP2EY,
and diphenyliodonium chloride (DPI), an inhibitor of P450 reductase, protected the
hepatocyte against Cr(VI)-induced cytotoxicity and Ïipid peroxidation. Jannetto et al
(2001) found cytochrome b5 played a key role in human microsomal chrornium(VI)
reduction. It acted as the mediator of electron transfer to Cr(VI) in NADPH-dependent
reduction of Cr(VI) process.
1.3.3.4 Other antioxidants
Besides above mentioned, the deferoxmine (DFO) and melatonin were also found to play
a protective role on Cr(VI)-induced cytotxicity and iipid peroxidation. Pretreatment of
primary cultures of rat hepatocytes with DFO or melatonin reduced ceils ftom both
Cr(VI)-induced cytotoxicity and lipid peroxidation (Susa et ai, 1997a, 1997b).
Pretreatment of human erythrocytes with DFO (4 mM) immediateiy inhibited
chromate-induced human erythrocytes peroxidation (Femandes et ai, 2000).
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1.3.4 Mitochondrial dysfunction
Isolated rat liver mitochondria have been shown to rapidly take up chromium from the
medium. Incubation of chromate with isolated rat liver mitochondria in vitro resulted in
the uptake and reduction of chromium(VI), as weii as the formation of the reactive
intermediates (chromium (V) species). Therefore, intact mitochondria might have the
ability to take up and reduce chromium(VI) and produce chromium(V) species in vitro.
Incubation of chromate with isolated rat liver submitochondriai particies under anaerobic
conditions in vitro resulted in reduction of Cr(VI) and increased the formation of Cr(V).
Since chromium(VI) is effectiveiy metabolized by mitochondria in vitro and
chrornium(V), the reactive intermediate, is formed in the process, mitochondria may play
a role in Cr(VI) carcinogenesis (Rossi and Wetterhahn, 1989; Rossi et ai, 1988).
Cr(VI)-induced apoptosis in Chinese hamster ovary (CHO) celis involves disruption of
mitochondrial stability. A dose-dependent release of mitochondrial cytochrome e (cyt c)
was observed in CHO ceils exposed to sodium chromate. Cyclosporin A (CsA), an
immuno-suppressant, affects the mitochondria by inhibiting the mitochondrial
permeability transition (MPT), thereby preventing disruption of the trans-membrane
potential. Co-treatment of CHO cells with CsA inhibited the release of cyt e and
markedly abrogated Cr(V1)-induced apoptosis, suggesting that the MPT plays an
important role in the regulation of mitochondrial cyt c release and that this may be a
critical point in the apoptotic pathway in which ceils are irreversibly comrnitted to death
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(Pritchard et ai, 2000). Another research showed that the oxygen consumption of isoiated
rat heart mitochondria was potently depressed in presence ofNa2CrO4, when NAD-linked
substrates were oxidized (Ryberg and Alexander, 1990).
1.4 Conclusion
To sum up, chromium compounds induce toxicity in many kinds of ceils, animais and
humans. Cr(VI) is more toxic than Cr(III) comparing with their toxicity. Cr(VI) is easier
to enter biologicai membrane to ceils than Cr(III). In ceils, Cr(VI) is metaboiized through
Cr(V), Cr(W), free radicals intermediates, to Cr(III) as ultimate product. $o the
generation of oxidative stress, lipid peroxidation, ceilular metabolism and mitochondrial
dysfunction induced by chromium may be the major mechanisms which resuit in
chromium-induced toxicity.
1.5 Objectives of the study
As a main accumulation, transport and excretion organ, kidney plays an important role in
chromium metabolism and is considered as the criticai excretory organ of ingested
chromium. Aimost ail of intravenously injected chromium is excreted via the urine.
Besides the main excretory organ, the kidney is also the main target organ for chromium
accumulation and toxicity. However, in view of above discussions it is evident that the
information regarding the mechanisms of Cr-induced nephrotoxicity is at present very
limited. The present study was therefore carried out to investigate the mechanisms of
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chromium [Cr(VI) and Cr(III)] induced toxicity in isolated rat renal cortical suces. And
the specific objectives ofthe research consist ofthe followings:
1). To study the nephrotoxicity potential (by measuring ceil viability) of potassium
dichromate [Cr(VI)] and chromium chloride [Cr(III)] in isolated rat renal cortical suces
and hence, to compare their renal toxicity using similar protocols.
2). To study and compare the mechanisms ofnephrotoxicity induced by Cr(VI) and Cr(III)
involving the following aspects:
(j) The roles of various reactive oxygen species (ROS) such as hydrogen peroxide,
superoxide anion and/or hydroxyl free radicals on Cr(VI)- and Cr(III)-induced
cytotoxicity (or celi viability) in isolated rat renal cortical suces.
(ii) The role of lipid peroxidation on Cr(VI)- and Cr(III)-induced cytotoxicity (or ceil
viability) in isolated rat renal cortical slices.
(iii)The role of various cellular antioxidants, such as glutathione, glutathione reductase,
vitamin C, vitamin E, melatonin and/or deferoxamine in Cr(VI)- and Cr(III)-induced
cytotoxicity (or cell viability) in isolated rat renal cortical suces.
(iv) The role of mitochondrial permeability transition on Cr(VI)-induced cytotoxicity (or
ceil viability) in isolated rat renal cortical slices.
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Abstract
The kidney is considered to be one of the target organs for toxicity of Cr(VI) compounds.
The information regarding the mechanisms of Cr(VI)-induced nephrotoxicity is however
at present very iimited. The present study was therefore carried out to investigate the
mechanisms of Cr(VI)(using potassium dichromate)-induced toxicity in isolated rat renal
cortical suces. The dichromate [Cr(VI)] showed both concentration (O - 4 mM) and time
(O — 3 hr) dependent cytotoxicity, as measured by MTT assay, measurement of the
toxicity with diphenyÏ-tetrazolium bromide. The dichromate [Cr(VI)] produced both
time-dependent significant depletion of nonprotein suifflydryl (NP-SH) contents and
significant increase in lipid peroxidation (LPO). Pretreatment of renal cortical suces with
either mannitol or dimethylthiourea (DMTU) failed to reduce Cr(VI)-induced toxicity but
reduced LPO. Pretreatment with either catalase or superoxide dismutase (SOD) failed to
reduce such toxicity and LPO. However, cotreatment with either excess glutathione
(GSH) or pretreatment with excess ascorbic acid (vitamin C) reduced both the Cr(VI)
induced toxicity and LPO. Although vitamin E and melatonin significantly reduced
Cr(VI)-induced LPO, they faiied to prevent Cr(VI)-induced cytotoxicity. Cr(VI) induced
mitochondrial permeability transition (MPT), but cyclosporine A (CsA), or camitine, or
trifluoperazine (inhibitors of MPT) faiÏed to prevent Cr(VI)-induced cytotoxicity,
suggesting a non-significant role of MPT in such toxicity. Pretreatment with carmustine
(BCNU) failed to prevent Cr(VI)-induced toxicity suggesting a nonsignificant foie of
renai glutathione reductase activity in such toxicity. The results suggest that intracellular
antioxidants vitamin C and giutathione might be the most determinant factors in Cr(VI)
induced oxidative stress and subsequent nephrotoxicity in isoiated rat renal cortical suces.
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Introduction
Occupationai exposure to chromium involves weiding, chrome-piating and manufacture
of chromium pigments (Verschoor et ai, 1988). Renal, hepatic and dermai toxicity have
been reported in industriai workers exposed to chromium(VI) (Love, 1923; Verschoor et
ai, 1988). Nephrotoxicity and hepatotoxicity have also been reported in experimental
animais (Appenroth and Bruniich, 1988; Hoj o and S atomi, 1991; Gunaratnam and
Grant, 2001; Laborda et ai, 1986; Seiken et ai, 1994).
Chromium reduction intermediates [Cr(V), Cr(IV) and Cr(III)] may be toxic since they
may invoive the production of ROS (Stohs et ai, 2000; Shi et ai, 1994; O’Brien and
Kortenkamp, 1994), which may be generated during physiologicai conditions. Various
types of reactive oxygen species (ROS), such as hydrogen peroxide (H202), superoxide
anion (02) and hydroxyl radicais (0H), have been impiicated in Cr(VI)-induced toxicity
in different celi unes, hepatocytes and other celis (Stohs et ai, 2000; O’Brien and
Kortenkamp, 1994); but no such information invoiving these types of ROS has been
cleariy estabiished in renai celis. Some intraceilular antioxidants are aiso involved in
Cr(VI) reduction, like glutathione (GSH), ascorbic acid (vitamin C), Œ-tocopheroi
(vitamin E) and giutathione reductase (GSSG-R). Furthermore, contradictory resuits have
been reported regarding the role of physiologicai giutathione in chromate-induced
nephtotoxicity in rats (Appenroth and Kersten, 1990; Standeven and Wetterhahn, 1991).
Contradictory resuits have also been reported regarding the role of enzymatic glutathione
reductase pathway in Cr(VI)-induced cytotoxicity in isolated rat hepatocytes
(Gunaratnarn and Grant, 2001; Pourahmad and O’Brien, 2001). However, the
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contribution of such enzymatic pathway in Cr(VI)-induced nephrotoxicity or cytotoxicity
in renal ceils lias flot been established yet. The mammalian pineal hormone melatonin and
deferoxamine (Df0) have also been reported to possess antioxidant activity in
scavenging free radicals (Pieri et ai, 1994; Reiter et ai, 1994; Susa et ai, 1997a and
1997b). But their roles in Cr(VI)-induced nephrotoxicity are stiil unknown.
The overail objective of this study was therefore to investigate whether Cr(VI)-induced
renal cellular injury (cytotoxicity) appeared to be mediated by the formation of ceiiuiar
reductive metabolism andlor ROS, such as hydrogen peroxide (H202), superoxide anion
(02) andlor hydroxyl radicals (0H). We have therefore examined the effects of
physiological antioxidants, particulariy the scavengers of ROS, as well as glutathione,
glutathione reductase, vitamins C and E, melatonin on potassium dichromate-induced
cellular damage in isolated renal cortical suces of rats, and the resuits are presented in
this paper.
Materials and methods
C’hemicals
Potassium dichromate (K2Cr2O7) was purchased from BDH Inc., Toronto, Canada.
Glutathione (GSH) was from Aidrich Chemicai Company. Ail other reagents and
chernicais were purchased ftom Sigma Chemical Company.
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Animais
Adult male Sprague-Dawley rats (220 - 280 g b.w.) (Charles River Canada Inc., $t.
Contant, Quebec) were used. They were maintained at constant temperature (22°C) with a
12 hr light! 12 hr dark photoperiod, housed 2-3 per cage on wood shavings and were fed
Purina Laboratory chow and tap water available ad libitum. Rats were acclimated for 3 to
5 days before experiments. The experimental protocols used in this study were approved
by the Ethics Committee of Université de Montréal.
Preparation of isoiated rat renai cortical suces and their treatment
Rats were anaesthetized with ‘Somnotal’ (0.1 ml!l00 g b.w. i.p.). They were decapitated
and exsanguinated, then the abdomen was opened; the kidneys were removed rapidly, de
capsulated, and immediately placed into ice-cold saline solution (0.14 M NaC1 and 0.02
M KC1). Following isolation of the kidneys, renal cortical suces (70 to 100 mg!per slice)
were prepared using a Stadie-Riggs Microtome, weighed and placed in a flask of 3 ml
ice-cold waymouth buffer medium (pH 7.4). Each group contained 4 suces. Rat renal
cortical suces were treated with potassium dichromate in waymouth medium (pH7.4) at
37°C and incubated in a rotating Dubnoff metabolic shaker at 150 rpm rotation in an
atmosphere of 95% oxygen and 5% carbon dioxide. Afler the incubation, renal cortical
suces were rernoved from the medium, dried with a filter paper and placed into other
plastic tubes containing 3 ml phosphate buffer solution (PBS, pH7.4). Renal cortical
suces were then homogenized in 3 ml PBS for 30sec. Half millilitre tissue hornogenate
was used to examine malondialdehyde (MDA), and I .Oml was for nonprotein-sulffiydryl
group (NP-SH). The residual tissue hornogenates were centrifuged at 2000 X g for 5 min
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to examine celi viability; 1.0 ml of the supematant was used (M’Bemba Meka and
Chakrabarti, 2001).
Determination of celi viability (cytotoxicity)
The celi viability was evaluated by the method based on the ability of mitochondrial
enzyme succinate dehydrogenase in living ceÏls to reduce the tetrazolium compound to a
soluble formazan product, which can be assayed colorimetrically. One millilitre of
supematant and 0.2 ml MTT solution (2.5 mg/ml PBS) were rnixed and incubated at 37°C
in water bath for 90 minutes in darkness. Absorbance was read at 570 nm using Beckman
DU-7 spectrophotometer. The resuit was expressed as celi viability as ¾ of control
(Mosmann, 1983).
Determination oflipidperoxidation (L?Q)
This was based on the formation of malondialdehyde (MDA), which reacted with
thiobarbituric acid to forrn red color. Half millilitre of the above tissue homogenate and
1.0 ml ofreagent solution (0.188 g thiobarbituric acid, 7.5 ml 10% oftrichloroacetic acid
and 1.1 ml concentrated HC1 mixed with distilled water to 50 ml volume) were mixed in
darkness, incubated at boiling water for 15 minutes, and then cooled in ice water
immediately to stop the reaction. The solution was then centrifuged at llOOxg for 15
minutes. The absorbance of the supematant was recorded at 535 nm using Beckman DU-
7 spectrophotometer. The concentration of MDA (nmoi/g tissue) was calculated using a
molar extinction coefficient of 1.56 X i05 M’cm1 (Poli et al. 1979, Valentovic et ai,
1999). The MDA was expressed as ¾ ofcontroi.
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Determination ofnonprotein-suljhydiyl groups (NP-SH)
The method was based on colorless DTNB reduced by SH group to form yeliow 2-nitro-
5-thiobenzoic acid, using L-cysteine as standard. One millilitre of homogenates were
mixed with 0.8 ml distilled water and 0.2 ml of 50% trichioroacetic acid (TCA). The
tubes were centrifuged for 15 min at 3000xg. Haif millilitre supematant was mixed with
1.0 ml of 0.4 M Tris buffer (pH 8.9) and 0.025 mi DTNB. The absorbance was read at
412 nm using Beckman DU-7 spectrophotometer within 5 min ofDTNB addition (Sedlak
and Lindsay, 1968). The resuit was finally calculated as L-cysteine as ¾ of control.
Determination ofrnitochondrial perrneability transition (MPT,)
The mitochondrial permeability transition (MPT) was measured as the uptake of
rhodamine 123, a cationic fluorescent dye that distributed across mitochondrial
membranes with respect to the trans-membrane potential. After being exposed to lmM
K2Cr2O7, the renal cortical suces was taken out from the incubation medium (waymouth
medium) and placed in Hanks’ Balanced Sait Solution (HBSS) containing 1.5 !LM/ml of
rhodamine 123, and incubated at 37CC for lOmin in a rotating metabolic shaker (l5Orpm),
and then change the suces to another 3m1 HBSS solution, respectively. Following
homogenisation and centrifugation, the uptake of rhodamine 123 in supematant was
measured fluorometricaily using a Perkin-Elmer MPF 3L fluorescence spectrophotometer
with excitation waveiength at 500 nm and emission waveiength at 522 nm. The capacity
of mitochondria to take up the cationic dye was caicuiated and expressed as percentage of
the total fluorescence of rhodarnine 123 in the supernatant (Chakrabarti and Demiiel,
1996; Wu et al, 1990).
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Statistics
The data were presented as the mean±SEM for 3-4 separate experiments. Differences
between groups were assessed by one-way analysis of variance (ANOVA, Tukey
analysis) or t-student test. P<0.05 was considered as statistically significant.
Resuits
Cr(VI)-induced cytotoxicity (‘C’ell viability), Ïipid peroxidation (MDA formation) and
nonprotein suljhydryl (NP-SH) contents in isotated rat renal cortical suces
The resuits of ccli viability, MDA formation and NP-SH contents were summarized in
Fig.2-1 and Fig.2-2. hi concentration-dependent study (Fig.2-1), the isolated rat renal
cortical suces were treated with 0, 0.125, 0.25, 0.5, 1.0, 2.0 and 4.0 mM K2Cr2O7 for 120
min. With increasing concentrations of Cr(VI), ccli viability was decreased significantly
in a concentration-dependent manner. MDA showed significant increase from 0.5 mM of
Cr(VI) compared to the control. NP-SH contents were significantly increased at low
concentration (0.125 mM) foÏlowed by significant decrease from 1.0 mM when compared
with control. In time-dependent study (Fig.2-2), the isolated rat renal cortical suces were
incubated with 1.OmM K2Cr2O7 for 30, 60, 90, 120 and 1$Omin. Cr(VI) significantly
reduced ccli viability afier 30 min of incubation and increased LPO after 90 min. NP-SH
contents showed a temporary increase at the beginning and then gradually decrease. After
incubation for 90 mm, NP-SH was significantly lower than that of control. It is seen that
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Cr(VI)-induced cytotoxicity occurred much earlier (30 mm) than LPO (90 mm) and NP
SH depletion (90 mm) in isolated rat renal cortical suces.
Effects of ROS on Cr(VI)-induced cet! viabilily and LPO in isolated rat renal cortical
s lices
The effects of ROS (such as H202, superoxide anion 02 and hydroxyl radicals) on
dichromate-induced cytotoxicity in isolated rat renal cortical suces were studied
indirectly by using scavengers of ROS. Thus, renal cortical suces were pretreated for 25
min with either catalase (scavenger of hydrogen peroxide, H202) (0, 2500 and 5000
U/ml), or superoxide dismutase (scavenger of superoxide anion, 02) (0, 1350 U/ml), or
mannitol (scavenger of hydroxyl radicals, 0H) (0, 25, 50 mM), or dimethylthiourea
(DMTU) (scavenger of 0H) (0, 25, 50 mM) followed by treatment with 0.5 mM
K2Cr2O7 for 90 min and the ceil viability was then measured in each case. The resuits are
presented in Fig.2-3. It is seen that the scavengers of different ROS failed to prevent
Cr(VI)-induced cytotoxicity. However, pre-treatment with either mannitol or DMTU
significantly reduced Cr(VI)-induced LPO, suggesting that reactive hydroxyl groups were
involved in such LPO. The antioxidants alone at concentrations used had no effects on
cytotoxicity or LPO compared to control (resuits not shown here).
The protective roles of antioxidants on Cr(VI,)-induced cytotoxicity and LPO in isolated
rat renal cortical suces
To examine the roles of other cellular antioxidants on Cr(VI)-induced cytotoxicity and
LPO, the isolated rat renal cortical slices were treated with 0.5 mlvi K2Cr2O7 for 90 min
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in the absence and presence of different antioxidants, such as reduced GSH (4 and 8
mM), ascorbic acid (vitamin C) (pretreatment: 2.5 mM and 5 mlvi for 45 mm), (±)-Œ
tocopherol (vitamin E) (pretreatment: 50 mM and 100 mM for 180 mm), melatonin
(pretreatment: 5 mlvi and 10 mM for 60 mm), and deferoxamine mesylate (DfO)
(pretreatment: 100 M for 15 mm). As seen from Fig.2-4, excess GSH and vitamin C
showed the ability to prevent Cr(VI)-induced celi viability loss and inhibit Cr(VI)
induced MDA formation. Although vitamin E and melatonin could reduce Cr(VI)
induced LPO, they failed to reduce Cr(VI)-induced cytotoxicity. DFO also could not
reduce Cr(VI)-induced cytotoxicity. The antioxidants alone at concentrations used had no
effects on cytotoxicity and LPO when compared to the respective control (resuits flot
shown here). These resuits indicated that only GSH and Vit.C have the potential to
protect Cr(VI)-induced cytotoxicity and LPO.
Effects ofglutathione reductase (‘GSSG-R,) on &(VI,)-induced cytotoxicity in isolated rat
renal cortical suces
To investigate the foie of glutathione reductase (GSSG-R) on Cr(VI)-induced
cytotoxicity, isolated rat renal cortical suces were treated with 0.5 mM K2Cr2O7 for 90
min in the absence and presence of either GSSG-R (pre-treatment: 20 U/mi for 15 mm) or
carmustine (BCNU) (an inhibitor of GS$G-R, pre-treatment: 1 and 2 mlvi for 30 mm).
The resuits are summarized in Fig.2-5. Pre-treatment of excess GSSG-R does not
significantly change Cr(VI)-induced cytotoxicity. Inhibition of GSSG-R by BCNU also
does flot protect Cr(VI)-induced cytotoxicity. Cannustine and GS$G-R alone at
concentrations used had no effect on cytotoxicity when compared to control (data not
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shown here). The resuits indicate that glutathione reductase did flot play an important role
in Cr(VI)-induced cytotoxicity in isolate rat renal cortical suces in vitro.
The role of mitochondrial perrneability transition (MPT) on Cr(VI)-induced cytotoxicity
in isoÏated rat renal cortical suces
To evaluate the role of mitochondrial permeability transition (MPT) on Cr(VI)-induced
cytotoxicity, time-dependent effect of Cr(VI)-induced MPT and the role of MPT blockers
on Cr(VI)-induced cytotoxicity were studied. The results are summarized in Fig.2-6 to
Fig.2-8. Fig.2-6 showed Cr(VI)-induced MPT (rhodamine 123 uptake) significantly
decreased starting from 10 min to 60 min when compared to the control value.
Pretreatment (Fig.2-7) or cotreatment (Fig.2-8) of renal cortical slices with MPT
blockers, such as cyclosporin A, camitine and trifluoperazin, did not reduce Cr(VI)
induced cytotoxicity, indicating Cr(VI)-induced cytotoxicity did flot resuit from Cr(VI)
induced MPT. The MPT blockers alone at concentrations used had no effect on MPT
compared to the control value (data not shown here).
Discussion
Acute exposure to Cr(VI) compounds has been reported to produce acute necrosis of
renal tubules (Franchini et al, 197$) andrenal lipoperoxidation in humans (Huang et al,
1999). This is in agreement with our present study. The biological effect of
chromium(VI) is generally considered to be due to cellular uptake because
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chromium(VI), in contrast to chromium(III), actively enters ceils by the sulfate anion
transport system (Jennette, 1979; Costa et ai, 1984). Once inside ceils, chromium(VI) is
believed to be subsequently reduced through reactive intermediates to chromium(III) by
celiular reductants. A great diversity of intraceilular reductants have been proposed to
contribute to the reduction of Cr(VI), including both non-enzymatic and enzymatic
mechanisms. Non-enzymatic mechanisms involving compounds such as reduced
glutathione (GSH), cysteine, hydrogen peroxide, and the vitamins (like vitamin C and
vitamin E) have been proposed (Sugiyama et ai, 1991 and 1989). Enzymatic reduction
has been demonstrated by giutathione reductase (Ning and Grant, 2000; Shi and Dalal,
1989), DT-diaphorase (Defiora et ai, 1985) and NADPH cytochrome C reductase and
cytochrome P-450-dependent system (Cupo and Wetterhalm, 1985) in ceilular systems
other than renai ceils.
The present study has shown that various reactive oxygen species (ROS) such as
hydrogen peroxide, superoxide anion, and hydroxyl radicais, have failed to influence the
potassium dichromate-induced cytotoxicity in rat renal cortical suces, as verified
indirectly by the failure of scavengers of these ROS to reduce such cytotoxicity. Such a
failure of Cr(VI)-induced ROS to influence other toxicities has also been reported. Thus,
the cytotoxicity induced by Cr(VI) in hurnan fibroblasts as detemiined by colony-forming
assay was not affected by catalase treatrnent (Snyder, 1988). Similariy, treatments with
cataiase (H202 scavenger), mannitol (hydroxyl radical scavenger), superoxide dismutase
and singlet oxygen scavengers such as 1,4-diaza-bicyclo[2,2,2]octane (DABCO) did not
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influence chromium(VI)-induced cytotoxicity in isolated rat hepatocytes, as evaluated by
the leakage of lactate dehydrogenase (Ueno et ai, 1989).
On the other hand, our present study has shown that scavengers of hydroxyl radicals,
such as mairnitol and dimethylthiourea (DMTU) have the potential to significantly reduce
potassium dichromate-induced lipid peroxidation in rat renal cortical suces, suggesting
that Cr(VI)-induced generation of hydroxyl radicals are responsible for Cr(VI)-induced
lipid peroxidation. Cr(VI) is thought to undergo redox cycling resulting in increased
production of such reactive oxygen species (Stohs et ai, 2000). The observation that
hydroxyl radical scavengers reduced dichromate-induced lipid peroxidation, but flot renal
cytotoxicity suggests that Cr(VI)-induced lipid peroxidation is not responsibie for Cr(VI)
induced cytotoxicity in rat renai cortical suces.
A number of eiectron spin resonance (ESR) studies have directly identified the formation
of paramagnetic Cr(V) species during reduction of Cr(VI) by reduced GSH (Sugiyama,
1992). Our resuits of inhibition ofCr(VI)-induced cytotxicity in rat renal cortical celis by
excess giutathione are in agreement with the in vivo study by Standeven and Wetterhahn
(1991). Thus, depletion of GSH by buthionine sulfoximine resulted in decreased body
weight gain, increased relative kidney weight, and increased blood urea nitrogen
concentration without affecting the renal uptake of chromate in the metal-treated rats
(Standeven and Wetterhahn, 1991). However, other study has shown an increase in
Cr(VI)-induced proteinuria foilowing pretreatment of rats with N-acetylcysteine
(Appenroth and Kersten, 1990). The ternporary increase of NP-SH contents in renal
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cortical suces at either lower concentration of Cr(VI), or at early time period of
incubation might be due to the release of protein-suifflydryl to protein and NP-SH, due to
the protein breakdown and hence, GSH biosynthesis. However, at higher concentration of
dichromate [Cr(VI)], significant GSH depletion occurs, presumably due to the production
of reactive intermediates, or ROS at a rate that exceeds the potential to regenerate GSH.
Both Cr(VI)-induced cytotoxicity and lipid peroxidation were inhibited by cotreatment
with excess GSH (4 amd 8 mM). This effect might be due to Cr(VI) reduced to Cr(III) by
GSH in the medium before it entered into renal celis, because only Cr(VI) could enter
celis readily and once inside the ceils it is reduced by intracellular reductant to a more
stable Cr(III). It is generally accepted that intracellular reduction of Cr(VI) is critical for
toxicity. If Cr(VI) is reduced to Cr(III) extracellularly, it will be difficuit to enter the celis
and produce the toxicity in ceils (Ning and Grant, 2000).
This study has shown that ascorbate pretreatment has significantly increased the ceil
viability reduced by dichromate, whereas such pretreatment significantly prevented
dichromate-induced increase in lipid peroxidation. On the other hand, Œ-tocopherol
pretreatment only prevented Cr(VI)-induced increase in lipid peroxidation without
protecting the ceil viability. Similarly, ceil survival as measured by colony-forming
efficiency assay showed that ascorbate, but flot Œ-tocopherol, protected Chinese hamster
ovary ceils (CHO-AA8 ccli une) from apopto sis induced by sodium chromate
(Blankenship et aÏ, 1997).
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lii vivo nephrotoxicity study has shown great differences in the protective capacity
against dichromate-induced nephrotoxicity between ascorbate and GSH. Pretreatment
with ascorbate completely abolished both the metabolic disturbance and nephrotoxicity
induced by dichromate (Na et ai, 1992). The resuits suggest that ascorbate-mediated
Cr(VI) reduction in kinetically more favorable than that of GSH in vivo. GSH levels are
about 5-foid higher than the ascorbate Ïeveis in the liver and kidney (Standeven and
Wetterhahn, 1991). fi vitro studies have shown that ascorbate reduces Cr(VI) at a faster
rate than GSH under physiological conditions (Connett and Wetterhahn, 1985; Suzuki
andFukuda, 1990).
Ascorbate lias been shown to be capable of reducing chromium(VI) to chromium(III)
(Connett and Wetterhahn, 1983). The ESR signal of chrornium(III) can be detected
immediately following the reaction of ascorbic acid and Na2CrO4 ($ugiyama et ai, 1991).
Since pretreatrnent with this reductant showed an increase in cellular levels of
chromium(III), the modification of the formation of those paramagnetic chromium
species by ascorbic acid might be caused by cellular reduction of chromum(VI) to
chromium(III) in ceils. Ascorbic acid has been reported to be present normally in
millimolar concentrations (2 - 5 mM) in humans and animal tissues (Homing, 1975) and
to be a more potent reductant of Cr(VI) than glutathione under physiological conditions
(Suzuki and fukuda, 1990). Vitamin E appears to play a role only as a scavenger of
hydroxyl radicaïs to reduce LPO caused by Cr(VI), but not cytotoxicity.
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Enzymatic reduction of Cr(VI) involving glutathione reductase resulted in toxicity in
cellular systems (Ning and Grant, 2000; Gunaratnam and Grant, 2001; Shi and Dalal,
1989). On the other hand, i.p. injection of sodium dichromate did not inhibit hepatic
glutathione reductase activity even at toxic doses (Standeven and Wetterhahn, 1991).
Similarly, pretreatment with carmustine (BCUN) (an inhibitor of glutathione reductase)
did not protect renal cortical ceils from Cr(VI)-induced cytotoxicity, suggesting that
glutathione reductase does not play any role in the intracellular reduction of Cr(VI) in
isoÏated rat renal cortical suces.
It is reported that DFO (an iron chelator) and melatonin (the pineal hormone) markedly
decreased potassium dichromate-induced DNA single-strand breaks as well as Cr(VI)
induced cytotoxicity and LPO in rat hepatocytes in culture (Susa et ai, 1997a and 1997b).
In this study, DFO did not reduce cytotoxicity in renal cortical celis and melatonin only
significantly suppressed Cr(VI)-induced lipid peroxidation, without reducing cytotoxicity
in renal cortical ceils. It is reported that melatonin had no effect on ceilular leveis of
GSH, the activity of glutathione reductase, superoxide dismutase. Similarly, cellular
uptake and distribution of Cr were flot affected by melatonin. However, melatonin caused
a 25% decrease in the levels of Cr(VI)-related hydroxyl radicals in rat hepatocytes in
culture in vitro (Susa et al, 1997b). Based on their study and our present study of
significant reduction of Cr(VI)-induced increase in LPO by mannitol and DMTU
(scavengers ofhydroxyl radicals), it is suggested that melatonin may significantly reduce
such increase in LPO by scavenging Cr(VI)-induced generation of toxic hydroxyl radicals
in renal cortical ceils.
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Cr(VI) inhibits mitochondrial respiration in vitro (Rossi and Wetterhalm, 1989). The
present study lias shown that dichromate induced MPT in isolated rat renal cortical suces;
but failure to prevent Cr(VI)-induced toxicity following pretreatment with permeability
transition pore sealing agents, such as cyciosporin A, camitine and trifluoperazine,
suggests a nonsignificant role of MPT in dichromate-induced renal toxicity. In contrast,
Cr(VI) (Cr042)-induced cytotoxicity was associated with Cr(VI)-induced MPT in
isolated rat hepatocytes (Pourahmad et ai, 2005).
In conclusion, mechanisms of potassium dichromate-induced cytotoxicity in isolated rat
renal cortical suces are somewhat different from those in other cellular systems including
isolated rat hepatocytes. The reactive oxygen species, such as H2O2, superoxide anion and
hydroxyl radicals failed to show any significant role in potassium dichromate [Cr(VI)]
induced renal cytotoxicity, and only hydroxyl radicals played a significant role in such
Cr(VI)-induced lipid peroxidation. Renal giutathione reductase and mitochondrial
permeabiiity transition appeared to play a nonsignificant role in such Cr(VI)-induced
cytotoxicity. On the other hand, the present study does suggest that intracellular
antioxidants such as Vitamin C and glutathione played a significant role not only in such
Cr(VI)-induced oxidative stress but also in cytotoxicity in rat renal cortical suces.
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Figure legend
fig.2- 1. Concentration-dependent effects of Cr(VI) on cytotoxicity, LPO and NP-SH
content after exposure to K2Cr2O7 for 120 min in isolated rat renal cortical suces.
Cytotoxicity was estimated by the MTT test, lipid peroxidation by the MDA
formation, and NP-SH contents by the DTNB test. The resuits were presented as
percent of control value. The data were mean ± SEM of four separate experiments.
*: significantly different from the corresponding control, p<O.05.
fig.2-2. Time-dependent effects of Cr(VI) on cytotoxicity, LPO and NP-SH content
after exposure at 1 mM K2Cr2O7 in isolated rat renal cortical suces. Cytotoxicity was
estimated by the MTT test, Iipid peroxidation by the MDA formation, and NP-SH
contents by the DTNB test. The resuits were presented as percent of control value.
The data were mean ± SEM of four separate experiments.
a: significantly different from the corresponding control, P<0.05
b: significantly different from the conesponding confrol, P<0.05
c: significantly different from the corresponding control, P<0.05.
f ig.2-3. Effects of scavengers of ROS on Cr(VI)-induced cytotoxicity and LPO in
isolated rat renal cortical suces. Ail the scavengers of ROS were pre-treated with
isolated rat renal cortical slices for 25 min followed by coincubation with 0.5 mM
K2Cr2O7 {Cr(VI)] for 90 min. The celi viability and MDA were measured as described
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in the text. The resuits were presented as percent of confrol value. The data were mean
+ SEM of four separated experiments.
a: significantly different from the conesponding control, P<0.05.
b: significantly different from corresponding Cr(VI) alone-treated group, P<0.05.
Fig.2-4. Effects of antioxidants on Cr(VI)-induced cytotoxicity and LPO in isolated
rat renal cortical suces. Excess GSH (4 mM and 8 mM) were cotreated with 0.5 mM
K2Cr2O7 for 90 mm, whereas other antioxidants, Vit.C (2.5 mM and 5.0 mM), or Vit.E
(50 mM and 100 mM), or melatonin (5 mM and 10 mM), or deferoxamine (DFO, 100
11M), were pre-treated for 45 mm, 180 mm, 60 min and 15 mm, respectively, before
treating with 0.5 mM K2Cr2O7 for 90 min. The resuits were presented as percent of
control value. The data were mean + SEM of four separate experiments.
a: significantly different from conesponding control, p<O.O5.
b:, significantly different from conesponding Cr(VI) aÏone-freated group, p<O.O5.
Fig.2-5. The role of GSSG-R and BCNU on Cr(VI)-induced cytotoxicity in isolated
rat renal cortical suces. GSSG-R (80 U/ml) and BCNU (1 mM and 2 mM) are
pretreated for 15 min and 30 mm, respectively, before exposure to 0.5 mM K2Cr2O7.
The results were presented as percent of control value. The data were mean ± SEM of
four separate experiments.
*: significantly different from control, P<0.05.
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Fig.2-6. Time-dependent effect of Cr(VI) on MPT after exposure to 1 mM K2Cr2O7 in
isolated rat renal cortical suces. The resuits were presented as percentage of the total
fluorescence of rhodamine 123. The data were mean ± SEM of four separate
experiments.
*: significantly different from the control, P<0.05
fig.2-7. Effects of cyclosporine A (CsA) pre-treatment on Cr(VI)-induced
cytotoxicity after exposure at 0.5 mM K2Cr2O7 for 90 min in isolated rat renal cortical
slices. CsA (15, 30 and 60 M) are pre-treated for 30 min before exposure to 0.5 mM
K2Cr2O7. The resuits were presented as percent of control value. The data were mean
± SEM of four separate experiments.
*: Significantly different from control, p<O.05.
fig.2-8. Effects of MPT blockers cotreatment on Cr(VI)-induced cytotoxicity after
exposure at 0.5 mM K2Cr2O7 for 90 min in isolated rat renal cortical suces Effects of
cotreatment with different MPT blockers on Cr(VI)-induced cytotoxicity after
exposure to 0.5 mM K2Cr2O7 for 90 min. The resuits were presented as percent of
control value. The data were mean ± SEM of four separate expenments.
*: Significantly different from control, p<O.O5.
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Abstract
Trivalent chromium compounds [Cr(III)] have been found to be nephrotoxic at high
concentration. However, less information is available regarding the mechanism of
Cr(III)-induced nephrotoxicity. In this study, isolated rat renal cortical suces were
exposed to different concentrations of chromium chloride (O-4mM) for 24Omin. Both
concentration- and time-dependent Cr(III)-induced cytotoxicity (as measured by MTT
test, the measurement of the toxicity with diphenyl-tetrazolium bromide) were observed.
However, neither concentration- nor time-dependent Cr(III)-induced lipid peroxidation
(LPO) [as rneasured by malondialdehyde (MDA) formation] was observed. Treatment of
renal cortical slices with mannitol or dimethyl thiourea (scavengers of hydroxyl ftee
radicals) failed to reduce Cr(III)-induced cytotoxicity, suggesting that reactive oxygen
species, such as hydroxyl free radicals, are flot involved in such toxicity. Co-treatment
with excess glutathione (especially 8 mM) increased Cr(III)-induced cytotoxicity and
LPO. Pre-treatment of renal cortical suces with vitamin C (5 mM) significantly reduced
Cr(III)-induced cytotoxicity, whereas pre-treatment with excess vitamin E failed to
reduce such toxicity. These data demonstrate that chrornium chloride at very high
concentration is cytotoxic to rat renal cortical slices and intracellular antioxidant vitarnin
C (ascorbic acid) might be an important determinant factor in such CrCÏ3-induced
cytotoxicity in isolated rat renal cortical celis.
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Introduction
Trivalent chromium [Cr(III)] compounds were considered before to be non-toxic. The
relationship between urinary chromium ami different forms of chromium has been
studied in workers exposed to chromium (Matczak et ai, 1990; 1995). Cr(III) compounds
may produce toxicity at relatively higher concentrations and]or depending on its chemical
forms (Bagchi et ai, 2002; 1997; Barcelaoux, 1999; Levis et ai, 1978).
An increase in lipid peroxidation (LPO) levels in liver and kidneys was observed
foliowing chromic oral treatment of rats with 0, 2.66, 5.23 and 10 g!kg per day of
chromium picolinate for 21 days. Superoxide dismutase (SOD), glutathione peroxidase
and glutathione (GSH) levels in the hepatic tissues were decreased in ail the treated
groups, while the hepatic catalase level decreased in the high dose group. The kidney
SOD and catalase levels also decreased in ail treated groups, while GSH and glutathione
reductase (GSSG-R) levels were reduced in the mid- and high-dose treated groups
(Mahboob et ai, 2002).
Chromium picolinate caused chromic renal failure in a 33-year-old wornan when she took
1200-2400 Lg/day for 4-5 months to enhance weight Ïoss. This case was presented with
weight loss, anemia, hemolysis, thrombocytopenia, liver dysfunction, increase in total
bilirubin, and renal failure (Cenilli et ai, 199$), suggesting that chromium(III) picolinate
causes serious renal impairment when ingested in excess. A second case of renai
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impairment was also observed in a 49-year old female nurse who ingested
600/Lg/chromium picolinate/day for 6 weeks for weight reduction (Wasser et ai, 1997).
Increased production of superoxide anion by rat peritoneal macrophages and hepatic
mitochondrial and microsomal lipid peroxidation was observed following oral
administration of chromium(III) chloride hexahydrate (895 mglkg b.w.) to female
$prague-Dawley rats. Chromium(III) picolinate and niacin-bound chromiurn(III) have
been shown to induce cytochrome C reduction, hydroxyl radical production and DNA
fragmentation in cuhured J744A. 1 marine macrophage ceils (Bagchi et ai, 2002). It has
been demonstrated that Cr(III) can be reduced to Cr(II) by the biological reductants L
cysteine and NADH resulting in the formation of Cr(II) which reacts with H202 to
generate hydroxyl radicals as detected by electron spin resonance (ESR) and HPLC
(Ozawa and Hanaki, 1990). Similarly, free radicals were generated by reaction with H202
and lipid hydroperoxides in the presence of Cr(I1I) (Shi et ai, 1993). These resuits
indicate that Cr(III) has the potentiai to generate free radicals from both H202 and lipid
hydroperoxides.
However, in this regard, the mechanism of CrCI3-induced renal ceilular injury is not
known yet. The overail objective of this study was therefore to investigate whether
Cr(III)-induced renal celiuiar injury or cytotoxicity appears to be mediated by the
formation of cellular reductive metabolism and/or reactive oxygen species such as
hydroxyl radicals. We have therefore examined the effects of physiologicai antioxidants
such as Vitarnin C (ascorbic acid), Vitarnin E (Œ-tocopheroi), and giutathione as weil as
the scavengers of reactive oxygen species (ROS), such as scavengers of hydroxyi free
6$
radicals on CrC13-induced cellular damage in isolated rat renal cortical suces and the
resuits are presented in this paper.
Materials and methods
Chemicais
Chromium chloride (CrC13), waymouth medium, 3 -(4,5 -dimethylthiazol-2-yl)-2,5-
diphenyl-tetrazolium bromide, thiobarbituric acid, mannitol, dimethyl thiourea (DMTU),
L-ascorbic acid (vitaminC), (+)-n-tocopherol (vitamin E), were obtained from Sigma
Chemical Company. Glutathione (GSH) was from Aldrich Chemical Cornpany.
Animais
Aduit male Sprague-Dawley rats (Charles River Canada Inc., St. Contant, Quebec) were
used. They were maintained at constant temperature (22°C) with a 12 hr light/ 12 hr dark
photoperiod, housed 2-3 per cage on wood shavings and were fed Purina Laboratory
chow and tap water available ad libitum. Rats were acclimated for 3 to 5 days and
weighed 220- 280 g at the tirne of expenments. The experimental protocols used in this
study were approved by the Ethics Committee on animal experiments, Université de
Montréal.
69
Preparation ofisoÏated rat renal cortical suces
Aduit male Sprague-Dawley rats were anaesthetized with ‘Somnotal’ (0.1 ml/100 g b.w.
i.p.). The rats were decapitated, exsanguinated, and then the abdomen was opened; the
kidneys were removed rapidly, de-capsulated, and immediately placed into ice-cold
saline solution (0.14 M NaCI and 0.02 M KCI). Following isolation of the kidneys, renal
cortical suces (70 to 100 mg/per suce) were prepared using a Stadie-Riggs Microtome,
weighed and placed in a flask of 3m1 ice-cold waymouth buffer medium (pH 7.4). Each
group contained 4 suces.
Rat renal cortical suces treatment
Rat renal cortical suces were treated with chromium chloride in waymouth medium (pH
7.4) and incubated at 37’C in a rotating Dubnoff metabolic shaker at 150 rpm in an
atmosphere of 95% oxygen and 5% carbon dioxide. After the incubation, renal cortical
slices were removed from the medium, dried with a filter paper and placed into other
plastic tubes containing 3 ml of phosphate buffer solution (P35, pH 7.4).
Tissue hoinogenization
Renal cortical suces were homogenized in 3 ml of P35 for 30 sec. Haif millilitre ofthe
tissue homogenate was used for malondialdehyde (MDA) estimation and 1.0 ml for
nonprotein suifflydryl group (NP-SH) contents evaluation. The remaining tissue
homogenate was centrifuged at 2000 X g for 5 min and the supernatants were used for
measurernent of celi viability.
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Determination ofcetl via bitity (‘cytotoxicity)
The ceil viability was measured by MTT cleavage assay. The method is based on the
ability of mitochondrial enzyme succinate dehydrogenase in living celis to reduce MIT
tetrazolium sait into MTT formazan. One millilitre of supematant ftom above and 0.2 ml
of MTT solution (2.5 mg/ml PBS) were rnixed and incubated at 37°C in water bath for
90 min. Absorbance was read at 570 nm using Beckman DU-7 spectrophotometer. The
cytotoxicity was evaluated as ce!! viability and expressed as percent of control value
(Mosmann, 1983).
Deterniination ofhpid peroxidation (LPO,)
Evaluation of lipid peroxidation was based on the formation of malondiaidehyde (MDA)
which reacts with thiobarbituric acid to form red color. Haif millilitre homogenate and
1.Oml reagent solution (0.188 g thiobarbituric acid, 7.5 ml 10% of trichioroacetic acid
and 1.1 ml concentrated hydrochioric acid were diluted to 50 ml volume with distilled
water) were rnixed in darkness, incubated at boiling water for 15 minutes, and then
coo!ed in ice water immediately to stop the reaction. The solution xvas centrifuged at
llOOxg for 15 minutes. The absorbance ofthe supematant was recorded at 535 nm using
Beckman DU-7 spectrophotometer. The concentration of MDA (nmol/G tissue) was
calculated using a molar extinction coefficient of 1.56 X l0 Mcrn1 (Poli et al. 1979,
Valentovic et aI, 1999). The resuit of MDA was finally expressed as MDA % ofcontrol.
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Statistics
The data were presented as the mean ± SEM for 4 separate experiments. Differences
between groups were assessed by one-way analysis of variance (ANOVA, Tukey
analysis) or t-student test. P<0.05 was considered as statistically significant.
Resuits
Cr(IH,)-induced cytotoxicity and lipidperoxidation (LPQ) in isolated rat renal cortical
suces.
Chromium chloride (CrC13)-induced cytotoxicity and lipid peroxidation were measured
and the resuits were summarized in Fig.3-1 and Fig.3-2. In concentration-dependent
study (fig.3-1), the isolated rat renal cortical suces were treated with 0, 1.0, 2.0 and 4.0
mM CrCÏ3 for 240 mm, respectively. With increasing concentrations of CrC13, ceil
viability gradually declined and be corne statistically significant at 4.0 mM CrC13 when
compared to control, (48.6 ¾ ofcontrol, p<O.Ol). In time-dependent study (Fig.3-2), the
renal cortical suces were exposed to 4.0 mM ofCrCl3 for 60, 120, 180, 240, 300 and 360
min. Celi viability and MDA were assessed. With increasing period of incubation, the
percentage of ccli viability significantly decreased starting at 120 min. But MDA
fonriation appeared non significant during different period of incubation when compared
to control.
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Effects of ROS on Cr(III)-induced cytotoxicity and LPO in isolated rat renal cortical
s lices.
In this study, the effects of scavengers of ROS, namely scavengers of hydroxyl free
radicals, on Cr(III)-induced cytotoxicity and LPO were rneasured. The resuits were
presented in fig.3-3. After co-treatment of renal cortical suces with either mannitol (25
and 50 mM) or dimethyl thiourea (DMTU) (10 and 20 mM) and 4.0 mM chromium
chloride for 240 miri, there was no change in Cr(III)-induced cytotoxicity in the presence
of mannitol or DMTU. Furthermore, these scavengers failed to change the LPO
compared to the groups of control and Cr(III)-treated alone.
Effects of GSH on cr(IH)-induced cytotoxicity and LFO in isolated rat renal cortical
s lices
Fig.3-4 presented the resuits of the effects of GSH cotreatment on Cr(III)-induced
cytotoxicity and LPO. The resuits showed with increasing concentration of GSH, Cr(III)
induced cytotoxicity and LPO were gradually increased compared to control and Cr(III)
treated alone. And cotreatrnent with 8 mM GSH enhanced Cr(III)-induced cytotoxicity
and LPO significantly compared to both control and Cr(III)-treated value (p<O.05).
Effects of vitamin C on Cr(HI,)-induced cvtotoxicity and vitamin E on &(111)-induced
cytotoxicity and LFO in isola ted rat renal cortical suces
Fig.3-5 presented the resuits of the effects of vitamin C on Cr(III)-induced cytotoxicity
and vitarnin E (Œ-tocopherol) on Cr(III)-induced cytotoxicity and LPO. Pre-treatment of
renal cortical suces with excess vitamin E for 120 min followed by incubation with 4 mM
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CrCY3 for 240 min did flot reduce Cr(III)-induced cytotoxicity. On the other hand, pre
treatment of renal cortical suces with excess vitamin C (5 mlvi) for 45 min followed by
treatment with 4 mlvi CrC13 for 240 min significantly reduced Cr(III)-induced
cytotoxicity, or significantly increased ceil viabiÏity compared to Cr(IÏI)-treated group
(p<O.05).
Discussion
The present study has shown that chromium chioride (CrC13) at very high concentrations
has the potential to damage rat renal cortical celis in vitro. Furthermore, in spite of sucli
high cytotoxic potentiai, CrC13 failed to induce iipid peroxidation at such high
concentration. Such a renal cytotoxic potentiai CrC13 at much higher concentration agrees
qualitatively with the resuits of some clinical studies (Cemili et ai, 199$; Wasser et ai,
1997). Lipid peroxidation is considered to be a marker of oxidative damage to the lipids
in kidney tissue. Such oxidative damage in lipids is usually caused by oxidation of lipids
by reactive oxygen species (ROS), such as superoxide anion, and hydroxyl radicals.
Since in our present study, chromium chloride failed to provide evidence of production of
such ROS, it is not therefore surprising that Cr(III) has faiied to generated such lipid
peroxidation. The failure to reduce Cr(III)-induced cytotoxicity (as measured by the MTT
test) in isolated rat renal cortical suces by modulators of free hydroxyl radicals such as
mannitol and dirnethyl thiourea suggests that the reactive oxygen species such as free
hydroxyl radicals are not involved in Cr(III)-induced cytotoxicity in renal cortical ceils.
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Our resuits are in contrast to the other reported studies. Thus, Bagchi et aI (2002)
obsewed significant increase in urinary excretion of various lipid metabolites foilowing
oral administration of chromium chloride hexahydrate (895 mg/kg b.w.) to female
Sprague-Dawley rats. They have aiso observed production of superoxide anion in
peritoneal macrophage and hepatic mitochondrial and microsomal lipid peroxidation
foilowing such in vivo study (Bagchi et ai, 2002). But no such information is availabie
ftom this study with regard to Cr(III)-induced ROS in renal ceils. Furthermore, the
production of hydroxyl free radicals by chromium(III) picolinate and niacin-bound
chromium(III) has been demonstrated in cultured J774A. 1 macrophage ceils (Bagchi et
ai, 2002). But our present study cannot support generation of such free hydroxyi radicais.
However, similar studies canied out in our laboratory have shown that ROS such as free
hydroxyl radicals played a significant role in potassium dichromate [Cr(VI)J-induced
cytotoxicity in isolated rat renal cortical suces (unpublished resuits).
Ozawa and Hanaki (1990) pointed that Cr(III) couid be reduced to Cr(II) ion by the
biological reductants, such as L-cysteine (thiol group) and NADH, and thus Cr(II) could
easily react with hydrogen peroxide to yield reactive oxygen species, hydroxyi radicais.
Similarly, in this research, cotreatment with high concentration (8mM) of excess
glutathione (thiol group also) significantly increases Cr(III)-induced cytotoxicity (celi
viability ioss) and the production of lipid peroxidation (Fig.3-4). The resuits suggest that
GSH caimot protect reiiai celis from Cr(III)-induced cytotoxicity, whereas it enhances
sucli toxicity and LPO production. This is in contrast to our other study where GSH
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played a protective role in potassium dichrornate [Cr(VI)]-induced cytotoxicity in
isolated rat renal cortical suces (unpublished resuits).
Pretreatrnent with excess vitamin E (a-tocopherol) faiÏed to increase ceil viability reduced
by CrC13, whereas pre-treatment of renal cortical suces with vitamin C (ascorbic acid)
significantly increased the celi viability reduced by CrC13.
In conclusion, these data demonstrate that CrC13 at very high concentration is cytotoxic to
rat renal cortical celis and intracellular antioxidant vitamin C (ascorbic acid) might be an
important determinant factor in sucli CrCÏ3-induced cytotoxicity in rat renal cortical ceils,
but GSH can enhance Cr(III)-induced cytotoxicity and LPO.
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Figure legend
Fig.3-1 Concentration-dependent effects ofCr(III) on cytotoxicity afier exposure to CrCl3
for 240 min in isoÏated rat renal cortical suces. Cytotoxicity was estimated by the MIT
test. The resuits were presented as ccli viability as percent of control value. The data were
mean * SEM of four separate experiments.
: significantly different from control, p<O.05.
f ig.3-2 Time-dependent effects of Cr(III) on cytotoxicity and LPO afier exposure to 4
mM CrC13 in isoÏated rat renal cortical suces. Cytotoxicity (as measured by the MTT test)
and iipid peroxidation (as rneasured by MDA formation) were measured at each time.
The results were presented as percent of control value. The data were mean + SEM of
four separate experiments. *: significantly different from control, p<O.O5.
fig.3-3 Effects of scavengers of free hydroxyl radicals on Cr(III)-induced cytotoxicity
and LPO afler exposure to 4 mM CrCl3 for 24Omin in isolated rat renal cortical suces.
The scavengers of free hydroxyl radicals such as maimitol and dimethyl thiourea
(DMTU) were coincubated with 4 mM CrC13 in isolated rat renal cortical suces for 240
min. The ccli viability (measured by MTT test) and LPO (measured by MDA formation)
were estimated as described in the text. The resuits were expressed as percent of controi
value. The values were mean ± SEM of four separated experiments. *: signiflcantly
different from control, p<O.05.
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fig.3-4 Effects of GSH on Cr(III)-induced cytotoxicity and LPO after exposure to 4 mM
CrC13 for 240 min in isolated rat renal cortical suces. Isolated rat renal cortical suces
were cotreated with 4 mM CrC13 and 4 or 8 mM GSH for 240 min. Celi viability
(cytotoxicity) and LPO (MDA formation) were then measured as described in the text.
The resuits are expressed as percent of control value. The data were mean ± SEM of four
separated experiments.
a: significantly different from conesponding control, p<O.05.
b: significantly different from corresponding Cr(III) (4 mM) alone-treated group, p<O.05.
Fig.3-5 Effects of vitamin C on Cr(III)-induced cytotoxicity and vitamin E on Cr(III)
induced cytotoxicity and LPO afier exposure to 4 mM CrC13 for 240 min in isolated rat
renal cortical slices. Isolated rat renal cortical slices were pretreated with either vitamin C
(2.5 mM and 5.0 mM) for 45 mm, or vitamin E (50 mM and 100 mM) for 120 mm,
followed by exposure to 4 mM CrC13 for 240 min. Cdl viabiÏity (cytotoxicity) and LPO
were then measured as described in the text. The results are expressed as percent of the
control value. The data are mean ± SEM of four separated experiments.
a: significantly different from corresponding control, p<O.O5.
b: significantly different ftom corresponding Cr(III) (4 mM) alone-treated group, p<O.O5.
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SECTION 4:
GENERAL DISCUSSION
Comparative studies of Cr(VI)- and Cr(III)-induced
nephrotoxicity in isolated rat renal cortical suces
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4.]. Cr(J7t9- and Cr(III)-induced cytotoxicitv in isolated rat renal cortical slices in
vitro
Chromium is known to have cytotoxic effects on celis. In general, Cr(VI)
demonstrated significantly higher toxicity than Cr(III). Our study has shown that both
Cr(VI) and Cr(III) induced concentration- and time-dependent effects on loss of ceil
viability in isoiated rat renal cortical suces (Fig.4-1 and Fig.4-2A). Ceil viability was
gradually reduced and produced significant great loss of celi viability starting at
exposure to 1 mM K2Cr2O7 {Cr(VI)] for 120 min (34.2% of control) compared to
exposure to 4 mM ofCrCl3 [Cr(III)j for 120 min (62.4% of control) in Fig.4-i. Thus,
Cr(III) presents a reiatively lower toxicity than that of Cr(VI) in isolated rat renal
cortical suces. Potassium dichromate-induced cytotoxicity is about $-foid higher than
that induced by chromium chloride in isolated rat renai cortical suces in vitro. These
resuits are similar to those in several human and murine celi unes (Flores and Perez,
1999). In diploid human fibroblastic celis (HFC), Cr(VI) compounds are i000-fold
more cytotoxic (LC50 is 0.5 1uM) than Cr(III) compounds (LC50 is 500 M)
(Biedermeim and Landolph, 1990). In rats, LD50 of sodium dichromate is only 50
rng/kg, but that of chromium chloride is up to 1790 rng/kg (Bagchi et ai, 2002). Such
a difference in cytotoxicity between Cr(VI) and Cr(III) can be ascribed to a
differential permeability of the plasma membranes due to two different oxidation
states of chromium. Ceil membranes have been found to be practically impermeable
to Cr(III), wliereas Cr(VI) lias been able to cross sucli biological membranes easily
(Appenroth and Kersten, 1990) and hence, exerts more toxic effects.
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4.2 The effects of reactive oxygeit species (R 0$) on Cr(VI)- and Cr(IH)-induced
cytotoxicity
Reactive oxygen species are beiieved to be invoived in the toxicity of chromium
compounds. Various types of ROS, such as F1202, superoxide anion and hydroxyl free
radicals have been impiicated in both Cr(VI)- and Cr(III)-induced toxicity in different
ceil unes, hepatocytes and other celis (Stohs et aI, 2000; O’Brien and Kortenkamp,
1994; Bagchi et ai, 2002). But in our study, pretreatment with either cataiase
(scavengers of H202), superoxide dismutase (scavenger of superoxide anion, 02)
failed to reduce both Cr(VI)-induced cytotoxicity and lipid peroxidation (LPO). On
the other hand, prefreatment of renal cortical suces with either mannitol (scavenger of
extraceilular hydroxyl free radicais), or dimethyl thiourea (DMTIJ) (scavenger of
intracellular hydroxyl free radicals) failed to reduce Cr(VI)-induced toxicity
(Fig.4-3A), but significantly reduce Cr(VI)-induced LPO (fig.4-3B). Similariy, both
mannitol and DMTU failed to inhibit CrC13 [Cr(III)]-induced cytotoxicity or, faiied to
increase the ceil viability reduced by CrC13 (Fig.4-3A). Thus, the reacfive oxygen
species do not play any significant role in both Cr(VI)- and Cr(III)-induced
cytotoxicity in rat renai cortical celis. In contrast to Cr(VI), CrCI3 [Cr(III)] does not
produce ROS and does not induce LPO in our study.
4.3 The mie ofgltttathione (G$H) on chroinittm-induced cytotoxicity aitd LPO
Giutathione is the most important antioxidant in celis or tissues. Hojo and Satomi
(1991) found that administration of Cr(VI) caused systemic and kidney injuries in
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mice, accompanying a lowering of renal GSH. In our study, we have observed that
potassium dichromate [Cr(VI)j caused GSH level (measured as NP-SH content) to
increase temporarily in Cr(VI) treatment at 0.125 mM for 120 min or 1 mM for 30
mm, but this level decreased significantly when the concentration or freatment time
was increased in isolated rat renal cortical suces (fig.2-1 and fig.2-2). Furthermore,
from Fig.4-4A and fig.4-43, we observed that cofreatment with excess reduced GSH
(4 mM and 8 mM) resulted in decreasing Cr(VI)-induced cytotoxicity and LPO,
whereas such cotreatment enhanced Cr(III)-induced cytotoxicity and produced
significant increase of LPO in isolated rat renal cortical suces, indicating that GSH
played a differential role in chromium-induced toxicity in isolated rat renal cortical
suces. One side, GSH plays a protective role on Cr(VI)-induced cytotoxicity and LPO.
On the other side, it enhances Cr(III)-induced cytotoxicity and LPO in isolated rat
renal cortical slices.
4.4 The role ofvitamin C and vitamin E in chromiuin—i,tduced cytotoxicity or LPO
To further compare the role of cellular antioxidants on Cr(VI)- and Cr(III)-induced
renal toxicity, we examined the effects of ascorbic acid (vitamin C) and Œ-tocopherol
(vitamin E) on Cr(VI)- and Cr(III)-induced toxicity. Prefreatment of vitamin C with
isolated rat renal cortical suces can reduce both Cr(VI)- and Cr(III)-induced ceil
viability loss and Cr(VI)-induced lipid peroxidation. However, pretreatment of
vitamin E failed ta reduce bath Cr(VI)- and Cr(III)-induced toxicity, but only reduce
Cr(VI)-induced LPO (fig.4-5). Thus, intracellular antioxidants vitamin C (ascorbic
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acid) might be the most determinant factors in potassium dichromate
[Cr(VI)]-induced oxidative stress and subsequent nephtotoxicity in isolated rat renal
cortical suces, whereas intracellular vitamin C seems to be the most important
determining factor in chromium chloride (CrC13)-induced nephrotoxicity in renal
cortical slices.
4.5 Conclusion
In our research, both Cr(VI) and Cr(III) have the potential to induce cytotoxicity in
isolated rat renal cortical suces, but with different degree. Cr(VI)-induced cytotoxicity
seems to be 8-fold higher than that of Cr(III) in isolated rat renal cortical suces in
vitro. Moreover, Cr(VI) [but flot Cr(III)] produced lipid peroxidation following the
occurrence of cytotoxicity. Reactive oxygen species (ROS) involving hydroxyl free
radicals are involved in Cr(VI)-induced LPO but flot cytotoxicity. Glutathione plays a
differential role in chromium cornpounds-induced cytotoxicity in isolated rat renal
cortical suces. One side, it plays a protective role in Cr(VI)-induced cytotoxicity and
LPO by decreasing ceil viability loss and MDA formation. On the other side, it
enhances Cr(III)-induced cytotoxicity and lipid peroxidation. Vitamin C is a powerful
cellular antioxidant to prevent both Cr(VI) and Cr(III)-induced renal toxicity, but not
vitamin E.
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Fig.4-1 Concentration-dependent effects of Cr(VI) and Cr(III) on cytotoxicity afier
exposure to different concentrations of K2Cr2O7 for 120 min and those of CrCI3 for 240
min in isolated rat renal cortical suces. Cytotoxicity is estimated by the MIT test. The
resuits are expressed as % of control value. The values are mean ± SEM of four separate
experirnents.
*: p<O.05, significantly different from control;
**: p<O.Ol, more significantly different from control.
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Fig.4-2 Time-dependent effects of Cr(VI) and Cr(III) on cytotoxicity (A) and lipid
peroxidation (B) after exposure to 1 mM K2Cr2O7 and 4 mM CrCI3 in isolated rat renal
cortical suces. Cytotoxicity was estimated by the MTT test. LPO was estimated by MDA
formation. The resuits are presented as % of control value. The values are mean ± SEM
of 4 separate experiments.
**: p<O.Ol, more significantly different from control.
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Fig.4-3 Effects of scavengers of free hydroxyl radicals (ROS) on Cr(VI)- and Cr(III)
induced cytotoxicity (A) and LPO (B) in isolated rat renal cortical suces. The scavengers
were cotreated with 0.5 mM K2Cr2O7 for 90 min or 4 mM CrC13 240 min in isolated rat
renal cortical suces. Cytotoxicity xvas estimated by the MTT test. LPO was estimated by
MDA formation. The resuits are presented as % of control value. The values are mean +
SEM of 4 separate experiments.
a: significantly different from control, p<O.05;
b: significantly different from corresponding chromium compounds, p<O.05.
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Fig.4-4 Effects of glutathione (GSH) on Cr(VI)- and Cr(III)-induced cytotoxicity (A) and
LPO (B) in isolated rat renal cortical suces. GSH was cotreated with 0.5 mM K2Cr2O7 for
90 min or 4 mlvi CrC13 for 240 min in isolated rat renal cortical suces. Cytotoxicity was
estimated by the MTT test. LPO was estimated by MDA formation. The resuits are
presented as % of control value. The values are mean ± SEM of 4 separate experiments.
a: significantly different from control, p<O.O5;
b: significantly different from Cr(VI) (0.5 mM) or Cr(III) (4 mM)-treated group, p<O.05.
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Fig.4-5 Effects of vitamin C on Cr(VI)- and Cr(III)-induced cytotoxicity (A) and Cr(VI)
induced LPO (B) and those of vitamin E on Cr(VT)- and Cr(III)-induced cytotoxicity (A)
and LPO(B) in isolated rat renal cortical suces. Vitamin C was pretreated for 45 min
before treatment with 0.5 mM K2Cr2O7 or 4 mM CrCI3. Vitamin E was pretreated for 180
min before treatment with 0.5 mM K2Cr2O7 and for 120 min before treatment with 4 mM
CrC13. Cytotoxicity was estimated as MTT test. LPO vas estimated as MDA formation.
The results are presented as % of control value. The values are mean ± SEM of 4 separate
experirnents.
a: significantly different from control, p<O.05;
b: significantly different from Cr(VI) (0.5mM) or Cr(III) (4mM)-treated group, p<O.OS.
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